Tuesday, January 26, 2010

Lupin Receives US FDA Tentative Approval For Memantine HCl Tablets

Lupin Pharmaceuticals, Inc. (LPI) voiced which it has perceived tentative capitulation from a US Food as well as Drug Administration (US FDA) for a Memantine Hydrochloride tablets, 5mg as well as 10mg. Lupin's Memantine HCl tablets have been AB-rated to Namenda tablets indicated for a diagnosis of moderate to serious dementia of a Alzheimer's type. Namenda had annual sales of we estimate $1...

No comments:

Post a Comment